Search research articles
Contact Us
Filters
Showing results (71-80 of 74) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 74 results.
Cancer Chemotherapy and Pharmacology
|
January 1, 1982
Pharmacokinetic approach to the selection of dose schedules for medroxyprogesterone acetate in clinical oncology
V Tamassia, A Battaglia, F Ganzina, et al.
Journal of Ethnopharmacology
|
March 19, 2013
Hemidesmus indicus induces apoptosis as well as differentiation in a human promyelocytic leukemic cell line
L Ferruzzi, E Turrini, S Burattini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 29, 2024
Early prediction of endocrine responsiveness in ER+/HER2-negative metastatic breast cancer (MBC): pilot study with <sup>18</sup>F-fluoroestradiol (<sup>18</sup>F-FES) CT/PET
A Gennari, E Brain, A De Censi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1988
Phase III randomized study of fluorouracil, epirubicin, and cyclophosphamide v fluorouracil, doxorubicin, and cyclophosphamide in advanced breast cancer: an Italian multicentre trial
, G Ambrosini, M Balli, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 74) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 74 results.
Cancer Chemotherapy and Pharmacology
|
January 1, 1982
Pharmacokinetic approach to the selection of dose schedules for medroxyprogesterone acetate in clinical oncology
V Tamassia, A Battaglia, F Ganzina, et al.
Journal of Ethnopharmacology
|
March 19, 2013
Hemidesmus indicus induces apoptosis as well as differentiation in a human promyelocytic leukemic cell line
L Ferruzzi, E Turrini, S Burattini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 29, 2024
Early prediction of endocrine responsiveness in ER+/HER2-negative metastatic breast cancer (MBC): pilot study with <sup>18</sup>F-fluoroestradiol (<sup>18</sup>F-FES) CT/PET
A Gennari, E Brain, A De Censi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1988
Phase III randomized study of fluorouracil, epirubicin, and cyclophosphamide v fluorouracil, doxorubicin, and cyclophosphamide in advanced breast cancer: an Italian multicentre trial
, G Ambrosini, M Balli, et al.
Page
of 8